Patents by Inventor Zeev ELKOSHI

Zeev ELKOSHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOPICAL CAPECITABINE FOR THE TREATMENT OF HYPERPROLIFERATIVE SKIN CONDITIONS
    Publication number: 20230172960
    Abstract: The present invention relates to a novel and unexpected method of using topical Capecitabine composition to obtain therapeutically effective amounts of fluorouracil (FU) within the skin of a subject afflicted with hyperproliferative or inflammatory skin condition. The method comprising topically administering a pharmaceutical composition comprising Capecitabine or a hydrate or solvate thereof to the affected area of the skin of the subject, to form therapeutically effective amounts of FU within the skin.
    Type: Application
    Filed: September 21, 2022
    Publication date: June 8, 2023
    Inventors: Avi AVRAMOFF, Helena SHIFRIN, Ron SCHLINGER, Tzviel SHESKIN, Zeev ELKOSHI
  • Topical capecitabine for the treatment of hyperproliferative skin conditions
    Patent number: 11559541
    Abstract: The present invention relates to a novel and unexpected method of using topical Capecitabine composition to obtain therapeutically effective amounts of fluorouracil (FU) within the skin of a subject afflicted with hyperproliferative or inflammatory skin condition. The method comprising topically administering a pharmaceutical composition comprising Capecitabine or a hydrate or solvate thereof to the affected area of the skin of the subject, to form therapeutically effective amounts of FU within the skin.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: January 24, 2023
    Assignee: TARO PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Avi Avramoff, Helena Shifrin, Ron Schlinger, Tzviel Sheskin, Zeev Elkoshi
  • TOPICAL CAPECITABINE FOR THE TREATMENT OF HYPERPROLIFERATIVE SKIN CONDITIONS
    Publication number: 20210052620
    Abstract: The present invention relates to a novel and unexpected method of using topical Capecitabine composition to obtain therapeutically effective amounts of fluorouracil (FU) within the skin of a subject afflicted with hyperproliferative or inflammatory skin condition. The method comprising topically administering a pharmaceutical composition comprising Capecitabine or a hydrate or solvate thereof to the affected area of the skin of the subject, to form therapeutically effective amounts of FU within the skin.
    Type: Application
    Filed: January 18, 2019
    Publication date: February 25, 2021
    Inventors: Avi AVRAMOFF, Helena SHIFRIN, Ron SCHLINGER, Tzviel SHESKIN, Zeev ELKOSHI